Answers are grounded in this paper and cite their sources.
Studies of the effectiveness of a new antiserotonin agent in patients with the carcinoid syndrome are described. Five of the seven patients tested had significant and objective evidence of improvement of symptoms. The clinical usefulness of this class of agents (antiserotonin) in the management of carcinoid patients is reemphasized.
No takes yet. Share an insight, caveat, or question.
Charles E. Mengel (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: